Does cost sharing really reduce inappropriate prescriptions among the elderly?

Font, Joan Costa; Toyama, Marin Gemmill

doi:10.1016/j.healthpol.2010.09.001

Cited by 6 publications

(6 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Lebanon, about 50% of antibiotics are used without a prescription, thereby without a diagnosis at the same time (Jamhour et al 2017). Prescribing errors may be numerous in the elderly (Costa-Font and Gemmill Toyama 2011;Mohan et al 2014). Biosensors and quick tests are already available for fast and reliable pathogen detection (Singh et al 2014;Nasseri et al 2018).…”

Section: Prescription and Sales Of Pharmaceuticalsmentioning

confidence: 99%

“…The abuse of and addiction to pharmaceuticals are more often observed, especially regarding painkillers, psychiatric drugs and sedatives (Costa-Font and Gemmill Toyama 2011;Borgschulte et al 2018). Furthermore, overdosing on prescription pharmaceuticals can be caused by differences between the established dose and the effective dose.…”

Section: Prescription and Sales Of Pharmaceuticalsmentioning

confidence: 99%

See 1 more Smart Citation

How to decrease pharmaceuticals in the environment? A review

Caban

Stepnowski

2021

Environ Chem Lett

View full text Add to dashboard Cite

The global problem of the presence of human and veterinary pharmaceuticals in the environment is under investigation. Despite the increase in the knowledge of its sources, fates and impacts, the assessment of risks and the derived prevention actions are limited to single cases. The predicted increasing trend in the usage of pharmaceuticals forces the various parties involved to think about comprehensive mitigation actions. There are many areas of daily human life and industrial operations where such actions should take place. Thereby, in the presented review, such actions were summarized and divided into the following groups: A. design, synthesis and production of pharmaceuticals, B. prescription, sales and waste handling, C. control of the sources with advanced technologies. As the total amount of proposed actions was found to be quite high, a ranking according to the term of effects was proposed using the pyramid of needs. The advantages of actions taken in the first steps of the pharmaceutical life cycle (acting on the upstream) over end-of-pipe actions and the application of advanced technologies (the downstream option) were discussed, with reference to expert opinions.

show abstract

Section: Prescription and Sales Of Pharmaceuticalsmentioning

confidence: 99%

Section: Prescription and Sales Of Pharmaceuticalsmentioning

confidence: 99%

How to decrease pharmaceuticals in the environment? A review

Caban

Stepnowski

2021

Environ Chem Lett

View full text Add to dashboard Cite

show abstract

“…There are also examples consistent with mistaken conclusions in the other direction, where the traditional model suggests low copays because insurees exhibit little price sensitivity, while incorporating behavioral hazard might suggest higher copays because the evidence signals persistent overuse. An example is the case of low price elasticities among the elderly for drugs deemed “inappropriate” for their conditions (Costa Font and Toyama 2011). …”

Section: The Pitfalls Of Ignoring Behavioral Hazardmentioning

confidence: 99%

Behavioral Hazard in Health Insurance

Baicker¹,

Mullainathan²,

Schwartzstein³

2012

View full text Add to dashboard Cite

A fundamental implication of standard moral hazard models is overuse of low-value medical care because copays are lower than costs. In these models, the demand curve alone can be used to make welfare statements, a fact relied on by much empirical work. There is ample evidence, though, that people misuse care for a different reason: mistakes, or “behavioral hazard.” Much high-value care is underused even when patient costs are low, and some useless care is bought even when patients face the full cost. In the presence of behavioral hazard, welfare calculations using only the demand curve can be off by orders of magnitude or even be the wrong sign. We derive optimal copay formulas that incorporate both moral and behavioral hazard, providing a theoretical foundation for value-based insurance design and a way to interpret behavioral “nudges.” Once behavioral hazard is taken into account, health insurance can do more than just provide financial protection—it can also improve health care efficiency.

show abstract

“…Better access to health information and education ('mediatisation') increases patient awareness of recommended or prescribed treatments [5]. A wider range and scope of information seeking and dissemination, spearheaded by the internet [11], has led to a growth of health information and such trends are set to continue as the number of internet users increase exponentially.…”

Section: Personalisation and Cost Sharingmentioning

confidence: 99%